ABOUT I-VASC
I-VASC Team collectively owns decades of experience in innovative minimally invasive devices, from product development to clinical application, market access and global commercialization

START

I-VASC was founded in 2015 with the goal of introducing its patented medical device for minimally invasive treatment of varicose veins to the global market.

ACHIEVEMENTS

I-VASC has proven its ability to successfully move from a concept idea to a viable product.

NEXT STEPS

  I-VASC team is committed to make Velex™ and other application of its Mt VESS™ platform technology commercially available for HCPs and patients around the world

START

I-VASC was founded in 2015 with the goal of introducing its patented Empty Vein Ablation (EVA) technology for the minimally invasive treatment of varicose veins to the global market.

RESULTS

I-VASC successfully moved from a conceptual idea to an innovative and fully validated product, by obtaining in 2021 the CE Mark certification for its VELEX™ system, catheter and handle

NEXT STEPS

I-VASC Team is committed to make VELEX™ and E.V.A. procedure commercially available to for patients and doctors around the world, and to develop new applications for its technology platform

PATENTS

The Empty Vein Ablation (EVA) technology is protected by a IP portfolio of several patents granted in all relevant global geographies

ENDORSMENTS

The I-VASC technology has received the endorsement of several global Key Opinion Leaders in vascular therapies

PATENTS

Six patents granted and Seven pending

PROTOTYPES

Four different series of prototypes developed

ENDORSMENTS

Key Opinion Leader endorsement

TESTED

Positive in ex vivo and in vivo pre-clinical testing

OUR TEAM

Management Team

Daniele Zanotti
Daniele Zanotti
CEO & Board Member
Over 30-year experience and track record in taking innovative medical technologies to market
Mario Salerno
Mario Salerno
CMO & Board member
MD, Vascular Surgery, Inventor, Head UOS ICS Maugeri IRCCS. Deep knowledge of vascular diseases, vascular surgery and innovative medical devices for vascular diseases
Cristiano Fontana
Cristiano Fontana
Business Dev & Board Member
Senior Manager ore 15 years’experience in medtech business dev, strategic advisory, fund raising value creation and commercialization
Ella Gilani
Ella Gilani
Executive Assistant and Operations
+5 years experience in customer service and relations, Back office, Marketing, and Providing high-level administrative support for company leaders to accomplish key tasks and company initiatives, Training administrative staff on company policies and best practices.
Emilio Roncoroni
Emilio Roncoroni
CFO
Over 25 years’ experiencein strategic consulting for SMEs. Extensive knowledge of marketing, administration and financial activities for startups and PMI
Attilio Castelli
Attilio Castelli
COO
Attilio Castelli is an Engineer with over 30 years’ experience in biomedical companies and in innovative medical devices technical creation and development
Milena Baselli
Milena Baselli
Business Development
PhD in experimental physics, currently enrolled in Executive Master in Finance at Bocconi
Marianna Luppi
Marianna Luppi
Regulatory Affairs
CARAQA expert class III/II devices USA, EMEA, APAC, of MDR and FDA 510(k). Was dir./resp. Affl.Med., Philips, Synclair, Sorin
Alessandro Stella
Alessandro Stella
RAQA Manager
Medical device expert with in depth knowledge EU MDR and IVDR, MDCG guidelines, clinical evaluation and investigation, regulatory strategy.

Scientific Advisors

Sergio Gianesini
Sergio Gianesini
Medical Board
Internationally recognized expert in venous and lymphatic disease, surgeon at the University of Ferrara (Italy), adjunct associate professor at the Uniformed Services University of Health Sciences (Bethesda, USA). He published more than 70 papers on venous-lymphatic topics, being invited as international speaker in more than 300 meetings. He has active roles in some of the most relevant international venous-lymphatic societies
Willy Chi
Willy Chi
Medical Board
Internationally recognized authority on venous and lymphatic disease, Professor of Medicine at the University of California, Davis, Vascular Center. He is widely published in the field of venous and lymphatic disease, and lectures globally. He is on the editorial board of Phlebology, Vascular Medicine, Veins and Lymphatic, and the Chinese Medical Journal
Sriram Narayanan
Sriram Narayanan
Medical Board
Experienced Chief Consultant with a demonstrated history of working in the hospital & health care industry. Skilled in Vascular, Clinical Research, Medical Education, Medical Devices, and Medicine. Expertise in medical device development, complex venous and aortic surgery